Sacubitril–valsartan versus enalapril for the treatment of acute decompensated heart failure in Chinese settings: A cost-effectiveness analysis

Overview of attention for article published in Frontiers in Pharmacology, March 2023

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 2 X users

Readers on

mendeley: 3 Mendeley

Summary X

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 6,539 followers.

RT @FrontPharmacol: New Research: Sacubitril–valsartan versus enalapril for the treatment of acute decompensated heart failure in Chinese s…

02 Mar 2023

Reply Repost Favourite

New Research: Sacubitril–valsartan versus enalapril for the treatment of acute decompensated heart failure in Chinese settings: A cost-effectiveness analysis https://t.co/QyirI4M6kT #pharmacology

02 Mar 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.